Microbiome Markers in Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Cancer, and Celiac Disease
International Journal of Molecular Sciences · 17.05.2025 · 26 (10) · 4818
DOI: 10.3390/ijms26104818 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.05.2025. Verfasst von M Isabel San-Martin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Area Biochemistry, Department of Molecular Biology, University of León, 24071 León, Spain. Hauptthemen laut MEDLINE: Celiac Disease, Inflammatory Bowel Diseases, Gastrointestinal Microbiome, Colorectal Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of León.
Abstract (Originalsprache)
Intestinal microbiota and the host’s immune system form a symbiotic alliance that sustains normal development and function in the human gut. Changes such as dietary habits among societies in developed countries have led to the development of unbalanced microbial populations in the gut, likely contributing to the dramatic increase in inflammatory diseases in the last few decades. Recent advances in DNA sequencing technologies have tremendously helped to characterize the microbiome associated with disease, both in identifying global alterations and discovering specific biomarkers that potentially contribute to disease pathogenesis, as evidenced by animal studies. Beyond bacterial alterations, non-bacterial components such as fungi, viruses, and microbial metabolites have been implicated in these diseases, influencing immune responses and gut homeostasis. Multi-omics approaches integrating metagenomics, metabolomics, and transcriptomics offer a more comprehensive understanding of the microbiome’s role in disease pathogenesis, paving the way for innovative diagnostic and therapeutic strategies. Unraveling the metagenomic profiles associated with disease may facilitate earlier diagnosis and intervention, as well as the development of more personalized and effective therapeutic strategies. This review synthesizes recent and relevant microbiome research studies aimed at characterizing the microbial signatures associated with inflammatory bowel disease, colorectal cancer, and celiac disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Area Biochemistry, Department of Molecular Biology, University of León, 24071 León, Spain.
- Instituto de Biología Molecular, Genómica y Proteómica (INBIOMIC), Universidad de León, Campus de Vegazana, 24071 León, Spain.
ORCID-Profile: M Isabel San-Martin, Alejandro Chamizo-Ampudia, África Sanchiz, Leandro Benito Rodríguez-Aparicio, Nicolás Navasa
Förderung
- University of León
Zitieren
APA
San-Martin, M. I., Chamizo-Ampudia, A., Sanchiz, Á., Ferrero, M. Á., Martínez-Blanco, H., Rodríguez-Aparicio, L. B., & Navasa, N. (2025). Microbiome Markers in Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Cancer, and Celiac Disease. International Journal of Molecular Sciences, 26(10), 4818. https://doi.org/10.3390/ijms26104818
Vancouver
San-Martin MI, Chamizo-Ampudia A, Sanchiz Á, Ferrero MÁ, Martínez-Blanco H, Rodríguez-Aparicio LB, et al. Microbiome Markers in Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Cancer, and Celiac Disease. International Journal of Molecular Sciences. 2025;26(10):4818. doi:10.3390/ijms26104818
BibTeX
@article{SanMartin2025,
author = {San-Martin, M Isabel and Chamizo-Ampudia, Alejandro and Sanchiz, África and Ferrero, Miguel Ángel and Martínez-Blanco, Honorina and Rodríguez-Aparicio, Leandro Benito and Navasa, Nicolás},
title = {Microbiome Markers in Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Cancer, and Celiac Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {10},
pages = {4818},
doi = {10.3390/ijms26104818}
}
EUVIMED